CERVAVAC

quadrivalent human papillomavirus vaccine · Serum Institute of India Pvt. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CERVAVAC, covering 2025-01-07 to 2025-01-07. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Evaluate SIIPL QHPV Vaccine (CERVAVAC®) in Women Living with HIV Aged 15-25 Years [Phase 3]